Retrospective study evaluates interventions affecting outcomes in head and neck cancer, suggesting potential benefits for patient health.
Concurrent chemoradiotherapy (CRT) with high-dose cisplatin is the standard non-surgical treatment for advanced head and neck cancer.However, treatment-related complications such as weight loss and muscle wasting are known prognostic factors that can negatively affect clinical outcomes.This retrospective study evaluated the effectiveness of supportive interventions, including in-hospital physical rehabilitation and the use of Kampo medicines (Rikkunshito and Ninjinyoeito) , administered during CRT.
No takes yet. Share an insight, caveat, or question.
Hori et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: